{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:23:00Z","timestamp":1786962180588,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ijrobp.2014.03.007","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:47:27Z","timestamp":1401842847000},"page":"547-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Neoadjuvant Chemoradiation Therapy Using Concurrent S-1 and Irinotecan in Rectal Cancer: Impact on Long-Term Clinical Outcomes and Prognostic Factors"],"prefix":"10.1016","volume":"89","author":[{"given":"Takatoshi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2014.03.007_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(93)90207-W","article-title":"Mesorectal excision for rectal cancer","volume":"341","author":"MacFarlane","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0936-6555(05)80319-X","article-title":"Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: A phase II study","volume":"5","author":"Cooper","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib3","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiation therapy for locally advanced rectal cancer: Results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.1995.13.6.1409","article-title":"Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer","volume":"13","author":"Minsky","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib5","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/1097-0142(19910601)67:11<2859::AID-CNCR2820671126>3.0.CO;2-W","article-title":"Preoperative high-dose leucovorin\/5-fluorouracil and radiation therapy for unresectable rectal cancer","volume":"67","author":"Minsky","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0360-3016(93)90307-H","article-title":"Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma","volume":"25","author":"Chan","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2004.06.206","article-title":"Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy","volume":"61","author":"Chan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0360-3016(02)03863-4","article-title":"Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer","volume":"55","author":"Mehta","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijrobp.2008.05.054","article-title":"Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3\/T4 rectal adenocarcinoma: ECOG E1297","volume":"72","author":"Rosenthal","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"R\u00f6del","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib11","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1200\/JCO.2000.18.20.3529","article-title":"Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer","volume":"18","author":"Hoff","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/annonc\/mdj041","article-title":"Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: A multicentric phase II study","volume":"17","author":"De Paoli","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.bjc.6603053","article-title":"Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: Results from a phase I\/II study","volume":"94","author":"Klautke","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.bjc.6604297","article-title":"Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer","volume":"98","author":"Koeberle","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib15","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2007.05.081","article-title":"Phase I trial of neoadjuvant preoperative chemotherapy with S-1 and irinotecan plus radiation in patients with locally advanced rectal cancer","volume":"69","author":"Sato","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2009.11.007","article-title":"A phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: Clinical feasibility and response rate","volume":"79","author":"Sato","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/annonc\/mdl173","article-title":"Alternative clinical end points in rectal cancer\u2014are we getting closer?","volume":"17","author":"Glynne-Jones","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib18","first-page":"465","article-title":"S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1\/FU human colon cancer xenografts resistant to 5-FU","volume":"16","author":"Nakata","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0006-2952(97)00541-8","article-title":"Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line","volume":"55","author":"Guichard","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.bjc.6601224","article-title":"Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil","volume":"89","author":"Yamada","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/14656566.9.7.1223","article-title":"Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere","volume":"9","author":"Sato","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib22","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1200\/JCO.2010.29.7697","article-title":"Preoperative chemoradiotherapy using concurrent capecitabine, and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: Impact on long-term clinical outcomes","volume":"29","author":"Gollins","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib24","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ijrobp.2006.07.1374","article-title":"Preoperative chemoradiation with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer; a matched-pair analysis","volume":"66","author":"Das","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib25","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial Accord 12\/0405-Prodige2","volume":"28","author":"Gerard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib26","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"R\u00f6del","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ijrobp.2009.06.019","article-title":"Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection","volume":"77","author":"Kim","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/SLA.0b013e3181f3f1b1","article-title":"Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01)","volume":"252","author":"Yeo","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib29","first-page":"1933","article-title":"Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer","volume":"28","author":"Katoh","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/bjs.6622","article-title":"Prognostic significance of peritoneal tumour cells identified at surgery for colorectal cancer","volume":"96","author":"Katoh","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11605-010-1379-4","article-title":"Anastomotic leakage contributes to the risk for systemic recurrence in stage II colorectal cancer","volume":"15","author":"Katoh","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib32","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1245\/s10434-011-1625-3","article-title":"Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer","volume":"18","author":"Katoh","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1535-6108(04)00115-1","article-title":"Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules","volume":"5","author":"Moeller","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis","volume":"10","author":"Yang","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc2397","article-title":"Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response","volume":"8","author":"Dewhirst","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2014.03.007_bib36","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ncomms1786","article-title":"Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels","volume":"3","author":"Harada","year":"2012","journal-title":"Nat Commun"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614002958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614002958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T07:29:35Z","timestamp":1565508575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614002958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0360301614002958"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.03.007","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant Chemoradiation Therapy Using Concurrent S-1 and Irinotecan in Rectal Cancer: Impact on Long-Term Clinical Outcomes and Prognostic Factors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}